Page 5 - டோனி மஜ்ஜுழ்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZEN Graphene Solutions Ltd.: ZEN Graphene Solutions Develops Novel Graphene-Based Potential Treatment for Bacterial and Viral Infections in Humans
ZEN Graphene Solutions Ltd. (TSXV: ZEN) (OTC Pink: ZENYF) (
ZEN or the
Company ) is pleased to announce that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound. Recently received testing results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including, upper and lower respiratory tract infections - where COVID-19 is a major contributor - as well as drug resistant organisms. Testing was conducted by Dr. Tony Mazzulli, MD, FRCPC, FACP, Microbiologist-in-Chief & Infectious Disease Specialist at Mount Sinai Hospital. Dr. Mazzulli is also a Professor at the Departments of Laboratory Medicine & Pathobiology ....

United States , United Kingdom , Greg Fenton , Candida Albicans , Tony Mazzulli , Francis Dube , Graphene Solutions Ltd , University Of Toronto , Newsfile Corp , Departments Of Laboratory Medicine Pathobiology , Health Canada , Regulation Services Provider , Venture Exchange , University Health , Mount Sinai Hospital Department , Infectious Disease Specialist , Mount Sinai , Laboratory Medicine , Minimum Inhibitory Concentrations , Graphene Compound , Intensive Care Unit , Albany Graphite Project , Solutions Ltd , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , கிரெக் ஃபெண்டன் ,